申请人:Lilly Industries Limited
公开号:US04123529A1
公开(公告)日:1978-10-31
Phenylpiperazine derivatives of formula (I): ##STR1## where R.sup.1 is benzyl, C.sub.1-6 alkyl or optionally substituted phenyl; R.sup.2 is optionally substituted phenyl; R.sup.3 is hydrogen or C.sub.1-4 alkyl; Q is furan, thiophene, oxazole or thiazole; m is 1 to 3 and n is 0 or 1; and pharmaceutically-acceptable salts thereof are active in the chemotherapy of immediate hypersensitivity conditions such as asthma.
公式(I)的苯基哌嗪衍生物:其中R.sup.1是苄基,C.sub.1-6烷基或可选择取代的苯基;R.sup.2是可选择取代的苯基;R.sup.3是氢或C.sub.1-4烷基;Q是呋喃,噻吩,噁唑或噻唑;m是1到3,n是0或1;其药学上可接受的盐在化疗中对立即型超敏反应症状如哮喘具有活性。